SV
Suman Vyas
About Suman Vyas
Data last updated:
Suman Vyas has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Bioheaven 360 Genotec Private Limited and Bioheaven Foundation. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Bioheaven 360 Genotec Private Limited at ₹1.86 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bioheaven 360 Genotec Private Limited U93010DL2018PTC331663 | Director | 27 Mar 2018 | 2018 | ₹1.86 Cr (FY 2024) | Active |
 Bioheaven Foundation U88900DL2025NPL457554 | Director | 03 Nov 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suman Vyas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suman Vyas
Suman Vyas has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Bioheaven 360 Genotec Private Limited and Bioheaven Foundation. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Bioheaven 360 Genotec Private Limited at ₹1.86 Cr (FY 2024).
Suman Vyas is associated with 2 companies as Director, including Bioheaven 360 Genotec Private Limited (₹1.86 Cr), Bioheaven Foundation.
Suman Vyas has expertise in General Business.
Suman Vyas has 8 years in corporate governance.
By reported revenue, the largest current company of Suman Vyas is Bioheaven 360 Genotec Private Limited, with revenue of ₹1.86 Cr (FY 2024).
Suman Vyas currently holds positions at 2 companies: Bioheaven 360 Genotec Private Limited (₹1.86 Cr), Bioheaven Foundation.